KSA National Immunization Schedule
Vaccine Information
Precautions to commonly
used vaccines
 VACCINE |
PRECAUTIONS TO COMMONLY USED VACCINES | |||||
|---|---|---|---|---|---|---|
| Influenza |
• Guillain-Barré syndrome (GBS) within 6 weeks after a previous dose of any
type of influenza vaccine • Moderate or severe acute illness with or without fever |
|||||
| DTaP |
• Guillain-Barré syndrome (GBS) within 6 weeks after previous dose of tetanustoxoid–containing vaccine • History of Arthus-type hypersensitivity reactions after a previous dose of diphtheria-toxoid–containing or tetanus-toxoid–containing vaccine; defer vaccination until at least 10 years have elapsed since the last tetanus-toxoid -containing vaccine • Progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, progressive encephalopathy; defer DTaP until neurologic status clarified and stabilized • Moderate or severe acute illness with or without fever |
|||||
| Hep.B | • Moderate or severe acute illness with or without fever | |||||
| Hep.A | • Moderate or severe acute illness with or without fever | |||||
| Hib | • Moderate or severe acute illness with or without fever | |||||
| IPV |
• Pregnancy • Moderate or severe acute illness with or without fever |
|||||
| HPV | • Moderate or severe acute illness with or without fever | |||||
| MenACWY |
• For MenACWY-CRM only: Preterm birth if less than age 9 months • Moderate or severe acute illness with or without fever |
|||||
| Rota |
• Altered immunocompetence other than SCID • Chronic gastrointestinal disease • RV1 only: Spina bifida or bladder exstrophy • Moderate or severe acute illness with or without fever |
|||||
| PCV | • Moderate or severe acute illness with or without fever | |||||
| PPV23 | • Moderate or severe acute illness with or without fever | |||||
| MMR |
• Recent (≤11 months) receipt of antibody-containing blood product
(specific interval depends on product) • History of thrombocytopenia or thrombocytopenic purpura • Need for tuberculin skin testing or interferon-gamma release assay (IGRA) testing • Moderate or severe acute illness with or without fever • For MMRV only: Personal or family (i.e., sibling or parent) history of seizures of any etiology |
|||||
| Varicella |
• Recent (≤11 months) receipt of antibody-containing blood product (specific
interval depends on product) • Receipt of specific antiviral drugs (acyclovir, famciclovir, or valacyclovir) 24 hours before vaccination (avoid use of these antiviral drugs for 14 days after vaccination) • Use of aspirin or aspirin-containing products • Moderate or severe acute illness with or without fever • If using MMRV, see MMR/MMRV for additional precautions |
|||||
* Click the vaccines to see footnotes
© 2023 Vaccine Information. Powered by Advances&More. All Rights Reserved.